Drugs / BioChaperone insulin lispro
last change Dec 2015 re-read 3 minutes ago

BioChaperone insulin lispro

Developed for
type 1 diabetes mellitus
Investigated by
Adocia · Eli Lilly and Company

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02528396 Aug → Dec 2015 type 1 diabetes mellitus Adocia Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BioChaperone insulin lispro ClinicalTrials.gov intervention name — accepted as the source's own label NCT02528396 ↗